• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE-N AUTOGUARD; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE-N AUTOGUARD; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 381811
Medical Device Problem Code Retraction Problem (1536)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 05/04/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that bd insyte-n autoguard needle difficult to retract.The following information was provided by the initial reporter: the needle did not retract easily when the retraction button was pushed.Customer responded on (b)(6).1.When you pressed the button, did the needle fully retract? yes, but the button needed to be pressed very firmly.2.Did the needle retract slower than normal? no.3.Did the needle start retracting and then stop, leaving the needle exposed? no.4.Did the needle not move at all after pressing the button? initially yes.It only moved when the button was pressed very firmly.5.Did the button depress? yes, with excess force.
 
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Additional Manufacturer Narrative
Additional information received.Annex e and f codes updated.Device evaluation: bd has confirmed customer complaints for devices with the reported batch, that during insertion of the catheter, the needle is slow to retract or fails to retract.The slow/no retraction may require repeated attempts at retraction of the needle by pressing the button.There is also the potential for a needle to remain exposed, despite shielding attempts.Bd is continuing to investigate the root cause and will take action to prevent recurrence of this issue.
 
Event or Problem Description
Customer responded on 13-jun."the was no serious harm to the patient or the hcp in this situation.There was minor harm to the patient as multiple iv attempts were required due to the malfunctioning of the device".Patient grid update.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE-N AUTOGUARD
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key22131832
Report Number1710034-2025-00937
Device Sequence Number7356847
Product Code FOZ
UDI-Device Identifier00382903818112
UDI-Public(01)00382903818112(11)240731(17)270731(10)4208538
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K201075
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility,Distributor
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 06/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number381811
Device Lot Number4208538
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/14/2025
Supplement Date Received by Manufacturer06/18/2025
Initial Report FDA Received Date06/03/2025
Supplement Report FDA Received Date06/19/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/31/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
MDS-25-5274
Patient Sequence Number1
Patient SexUnknown
-
-